Telomir Pharmaceuticals, Inc.

Biotechnology • Healthcare • Miami, FL, United States • TELO (NCM)

Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on reversing biological aging and degenerative diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Progeria, Wilson's disease, and age-related macular degeneration (amd), as well as type 2 diabetes, cancer, and Alzheimer's disease. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.

786 396 6723 100 SE 2nd Street, Miami, FL 33131, United States

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Telomir Pharmaceuticals Inc. (TELO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

StocksToTrade • Dec 27

Why Telomir Pharmaceuticals Stock Is Rising 40% Premarket Today - Stocktwits

Stocktwits • Oct 9

Telomir Pharmaceuticals sets CEO incentive awards and salary adjustment - Investing.com

Investing.com • Dec 22

Will Telomir Pharmaceuticals Bounce Back? - StocksToTrade

StocksToTrade • Nov 21

Telomir Pharma (NASDAQ: TELO) Telomir-1 Shows Preclinical HL60 Leukemia Activity - Stock Titan

Stock Titan • Nov 21

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Telomir Pharmaceuticals, Inc. had layoffs?

No layoff events have been recorded for Telomir Pharmaceuticals, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is Telomir Pharmaceuticals, Inc. in?

Telomir Pharmaceuticals, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Telomir Pharmaceuticals, Inc. a publicly traded company?

Yes, Telomir Pharmaceuticals, Inc. is publicly traded under the ticker symbol TELO on the NCM. The company has a market capitalization of approximately $0.05 billion.

Where is Telomir Pharmaceuticals, Inc. headquartered?

Telomir Pharmaceuticals, Inc. is headquartered in Miami, FL, United States at 100 SE 2nd Street, Miami, FL 33131, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.